Bernstein Reiterates $39.00 Price Target for Pfizer, Inc. (NYSE:PFE)

Bruno Cirelli
Agosto 5, 2017

Many analysts have provided their estimated foresights on Pfizer Inc. The biopharmaceutical company reported $0.67 EPS for the quarter, topping the consensus estimate of $0.65 by $0.02. They now have a Dollars 38 price target on the stock. Dolsten Mikael sold $1.07 million worth of stock or 30,970 shares. Investors of record on Friday, August 4th will be issued a dividend of $0.32 per share. It has underperformed by 3.98% the S&P500. River Wealth Advisors LLC raised its position in Pfizer by 0.3% in the second quarter. Plancorp Llc acquired 26,491 shares as Pfizer Inc (PFE)'s stock declined 3.45%. The Lakeview Capital Partners Llc holds 37,737 shares with $1.23M value, down from 50,267 last quarter. Pfizer Inc now has $201.10 billion valuation. The stock increased 1.55% or $0.51 during the last trading session, reaching $33.43. (NYSE:PFE). State Of Tennessee Treasury Department holds 3.99M shares. Pfizer Inc. (NYSE:PFE) has declined 2.76% since August 4, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

07/28/2017 - Pfizer, Inc. had its " rating reiterated by analysts at UBS. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and ten have issued a buy rating to the stock. The rating was maintained by Macquarie Research with "Buy" on Tuesday, July 25. The company was maintained on Friday, August 28 by Piper Jaffray. DA Davidson maintained the shares of T in report on Monday, March 7 with "Buy" rating. Keefe Bruyette & Woods maintained Ally Financial Inc (NYSE:ALLY) rating on Thursday, July 27. Jefferies downgraded the stock to "Hold" rating in Thursday, October 13 report. The company was maintained on Monday, May 2 by Leerink Swann. On Thursday, May 12 the stock rating was initiated by Berenberg with "Hold". The firm has "Buy" rating given on Wednesday, October 28 by Maxim Group.

Investors sentiment decreased to 1.19 in Q4 2016. Its up 0.14, from 1.02 in 2016Q3. It is negative, as 60 investors sold PFE shares while 672 reduced holdings.

Atika Capital Management Llc, which manages about $167.96 million US Long portfolio, upped its stake in Exelixis Inc (NASDAQ:EXEL) by 25,000 shares to 80,000 shares, valued at $1.19 million in 2016Q4, according to the filing. Letko Brosseau & Associates has invested 1.28% in Pfizer Inc. (NYSE:T). Madison Invest Holding Inc owns 23,917 shares. Lafayette holds 0.27% in Pfizer Inc. Schnieders Cap Mngmt Limited Co holds 0.79% or 47,403 shares in its portfolio. During the same quarter in the prior year, the firm earned $0.64 earnings per share. Jane Street Grp Limited Liability Corp owns 21,668 shares for 0.01% of their portfolio. Wasatch owns 242,965 shares. Howe And Rusling Inc invested 2.47% of its portfolio in AT&T Inc. Arrow Financial reported 1.24% in Pfizer Inc.


Evanson Asset Mngmt Ltd Liability Corporation accumulated 14,701 shares. The stock's average target of $46 is 13.72% above today's ($40.45) share price. Algebris Investments Llp who had been investing in Ally Finl Inc for a number of months, seems to be bullish on the $10.28B market cap company.

Since February 10, 2017, it had 0 insider buys, and 6 insider sales for $4.43 million activity. Shares for $153,855 were sold by JOHNSON RADY A. (PFE) stands at 27.73. Shares for $1.23 million were sold by HILL CHARLES H. The insider LANKLER DOUGLAS M sold 20,000 shares worth $693,200. Zacks Investment Research upgraded shares of Pfizer from a "sell" rating to a "hold" rating in a research report on Friday, July 14th. Therefore 30% are positive. Arlington Asset Investment had 15 analyst reports since August 5, 2015 according to SRatingsIntel.

Several equities analysts recently issued reports on PFE shares.

Yet another important factor while evaluating a good buy/sell decision for Pfizer Inc. (NYSE:PFE) earned "Overweight" rating by Piper Jaffray on Saturday, September 5. Trend analysis is based on historical data about the stock's performance given the overall trends of the market and particular indicators within the market. On Monday, May 9 the stock rating was maintained by Credit Suisse with "Outperform". Jefferies downgraded Pfizer Inc. More interesting news about Pfizer Inc. (PFE) opened at 33.43 on Friday. BMO Capital Markets upgraded Pfizer from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $33.00 to $37.00 in a research report on Wednesday.

Altre relazioni OverNewsmagazine

Discuti questo articolo